Dina Burstein

421 total citations
18 papers, 323 citations indexed

About

Dina Burstein is a scholar working on Public Health, Environmental and Occupational Health, Clinical Psychology and Epidemiology. According to data from OpenAlex, Dina Burstein has authored 18 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 6 papers in Clinical Psychology and 6 papers in Epidemiology. Recurrent topics in Dina Burstein's work include Opioid Use Disorder Treatment (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). Dina Burstein is often cited by papers focused on Opioid Use Disorder Treatment (8 papers), Substance Abuse Treatment and Outcomes (5 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). Dina Burstein collaborates with scholars based in United States. Dina Burstein's co-authors include Traci C. Green, Alexander Y. Walley, Jeffrey Bratberg, Patricia Case, Janette Baird, Elizabeth Donovan, Janette Baird, Robert Sege, Kay Johnson and Jeff Linkenbach and has published in prestigious journals such as International Journal of Environmental Research and Public Health, MMWR Morbidity and Mortality Weekly Report and JAMA Network Open.

In The Last Decade

Dina Burstein

15 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Burstein United States 9 278 178 84 54 50 18 323
Lindsay A Pearce Canada 9 243 0.9× 188 1.1× 16 0.2× 43 0.8× 46 0.9× 22 356
Sharmini Radakrishnan United States 5 268 1.0× 97 0.5× 57 0.7× 107 2.0× 40 0.8× 9 320
Bianca Rivera United States 9 299 1.1× 227 1.3× 25 0.3× 40 0.7× 33 0.7× 19 359
Martha J. Wunsch United States 8 277 1.0× 127 0.7× 31 0.4× 103 1.9× 51 1.0× 16 361
Tonya Campbell Canada 11 265 1.0× 190 1.1× 30 0.4× 62 1.1× 45 0.9× 26 330
Payel Roy United States 10 460 1.7× 354 2.0× 73 0.9× 98 1.8× 41 0.8× 23 564
Shara Martel United States 12 306 1.1× 205 1.2× 34 0.4× 54 1.0× 135 2.7× 19 413
Donna Beers United States 7 303 1.1× 170 1.0× 44 0.5× 104 1.9× 25 0.5× 12 361
Marie-Ève Goyer Canada 6 399 1.4× 269 1.5× 30 0.4× 96 1.8× 51 1.0× 11 451
Eric Hulsey United States 10 265 1.0× 214 1.2× 22 0.3× 32 0.6× 57 1.1× 28 384

Countries citing papers authored by Dina Burstein

Since Specialization
Citations

This map shows the geographic impact of Dina Burstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Burstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Burstein more than expected).

Fields of papers citing papers by Dina Burstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Burstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Burstein. The network helps show where Dina Burstein may publish in the future.

Co-authorship network of co-authors of Dina Burstein

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Burstein. A scholar is included among the top collaborators of Dina Burstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Burstein. Dina Burstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hero, Joachim O., Dina Burstein, Sydne J Newberry, et al.. (2025). Health Associations of Positive Childhood Experiences: A Scoping Review of the Literature. International Journal of Environmental Research and Public Health. 22(1). 59–59.
2.
Sege, Robert, Maria Aslam, Cora Peterson, et al.. (2025). Positive Childhood Experiences and Adult Health and Opportunity Outcomes in 4 US States. JAMA Network Open. 8(7). e2524435–e2524435.
3.
Sege, Robert, Dina Burstein, Phyllis Holditch Niolon, et al.. (2024). Predictors of Corporal Punishment during the COVID-19 Pandemic. Pediatric Reports. 16(2). 300–312.
4.
Sege, Robert, Elizabeth A. Swedo, Dina Burstein, et al.. (2024). Prevalence of Positive Childhood Experiences Among Adults — Behavioral Risk Factor Surveillance System, Four States, 2015–2021. MMWR Morbidity and Mortality Weekly Report. 73(17). 399–404. 6 indexed citations
5.
Sege, Robert, et al.. (2023). Childcare Disruptions and Parental Stress During the COVID-19 Pandemic. Journal of Developmental & Behavioral Pediatrics. 45(1). e21–e30. 1 indexed citations
6.
Burstein, Dina, et al.. (2023). Protective factors associated with reduced substance use and depression among gender minority teens. Journal of LGBT Youth. 21(4). 659–676. 3 indexed citations
7.
Burstein, Dina, Jing Yang, Kay Johnson, Jeff Linkenbach, & Robert Sege. (2021). Transforming Practice with HOPE (Healthy Outcomes from Positive Experiences). Maternal and Child Health Journal. 25(7). 1019–1024. 28 indexed citations
8.
Donovan, Elizabeth, Jeffrey Bratberg, Janette Baird, et al.. (2020). Pharmacy leaders’ beliefs about how pharmacies can support a sustainable approach to providing naloxone to the community. Research in Social and Administrative Pharmacy. 16(10). 1493–1497. 12 indexed citations
9.
Green, Traci C., Dina Burstein, Ziming Xuan, et al.. (2020). Pharmacy On-Site Overdose Protocols and Prevention of Overdose. Substance Abuse. 43(1). 64–68. 8 indexed citations
10.
Green, Traci C., Elizabeth Donovan, Patricia Case, et al.. (2020). Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches. Journal of the American Pharmacists Association. 60(5). 740–749. 19 indexed citations
11.
Donovan, Elizabeth, Patricia Case, Jeffrey Bratberg, et al.. (2019). Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose. Journal of Urban Health. 96(3). 367–378. 46 indexed citations
12.
Burstein, Dina, Janette Baird, Jeffrey Bratberg, et al.. (2019). Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study. Journal of the American Pharmacists Association. 60(2). 304–310. 13 indexed citations
13.
Green, Traci C., Jeffrey Bratberg, Janette Baird, et al.. (2019). Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy. International Journal of Drug Policy. 85. 102602–102602. 24 indexed citations
14.
Baird, Janette, Dina Burstein, Ziming Xuan, et al.. (2019). Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians. Journal of the American Pharmacists Association. 59(6). 824–831. 15 indexed citations
15.
Burstein, Dina, et al.. (2019). A Full-Thickness Burn in a Teenager Resulting from Prolonged Contact with a Mobile Phone Charging Cube: A Case Report.. PubMed. 102(9). 43–44. 1 indexed citations
16.
Mello, Michael J., Dina Burstein, Janette Baird, et al.. (2018). Formative research to underpin a text messaging home safety intervention for young mothers. Health Education Journal. 78(3). 266–272. 4 indexed citations
17.
Burstein, Dina, Mark R. Zonfrillo, Janette Baird, & Michael J. Mello. (2017). Child Passenger Safety Technician Consultation in the Pediatric Primary Care Setting. Clinical Pediatrics. 56(10). 928–933. 15 indexed citations
18.
Green, Traci C., Patricia Case, Janette Baird, et al.. (2017). Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states. Journal of the American Pharmacists Association. 57(2). S19–S27.e4. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lindsay A Pearce Breakdown of academic impact, for papers by Sharmini Radakrishnan Breakdown of academic impact, for papers by Bianca Rivera Breakdown of academic impact, for papers by Martha J. Wunsch Breakdown of academic impact, for papers by Tonya Campbell Breakdown of academic impact, for papers by Payel Roy Breakdown of academic impact, for papers by Shara Martel Breakdown of academic impact, for papers by Donna Beers Breakdown of academic impact, for papers by Marie-Ève Goyer Breakdown of academic impact, for papers by Eric Hulsey
Rankless by CCL
2026